<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Contraception</journal-id><journal-id journal-id-type="iso-abbrev">Contraception</journal-id><journal-title-group><journal-title>Contraception</journal-title></journal-title-group><issn pub-type="ppub">0010-7824</issn><issn pub-type="epub">1879-0518</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27312266</article-id><article-id pub-id-type="pmc">5357721</article-id><article-id pub-id-type="publisher-id">S0010-7824(16)30113-5</article-id><article-id pub-id-type="doi">10.1016/j.contraception.2016.06.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>Corrigendum to &#x0201c;Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A&#x0201d; [Contraception 2016;93:498&#x02013;506]</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rowe</surname><given-names>Patrick</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Farley</surname><given-names>Tim</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Peregoudov</surname><given-names>Alexandre</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Piaggio</surname><given-names>Gilda</given-names></name><xref rid="af0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Boccard</surname><given-names>Simone</given-names></name><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Landoulsi</surname><given-names>Sihem</given-names></name><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Meirik</surname><given-names>Olav</given-names></name><email>olav.meirik@gmx.com</email><xref rid="af0020" ref-type="aff">d</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><collab>for the IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction</collab><xref rid="fn0005" ref-type="fn">1</xref></contrib></contrib-group><aff id="af0005"><label>a</label>UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland</aff><aff id="af0010"><label>b</label>Medical Statistics Department, London School of Hygiene and Tropical Medicine, London, UK</aff><aff id="af0015"><label>c</label>Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland</aff><aff id="af0020"><label>d</label>Instituto Chileno de Medicina Reproductiva (ICMER), Santiago, Chile</aff><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author. <email>olav.meirik@gmx.com</email></corresp><fn id="fn0005"><label>1</label><p id="np0005">The IUD Research Group of the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Centres and Principal Investigators participating in the conduct of trial: Brazil, Juiz de Flora, Dr. A Andrade; Chile, Santiago, Hospital E. Barros Lucos-Trudeau, Dr. P Lavin; Chile, Temuco, Universidad de la Frontera, Dr. P Valdes; China, Wuhan, Dr. Wu Xi Rui; China, Tianjin, Dr. Cao Xiao Ming; China, Shanghai Xin Hua, Dr. Liu Qing-Xi; China, Shanghai Ren Ji, Dr. Wu Yu-Feng; China, Shanghai IPP, Dr. Feng Zuan Chong; China, Shanghai IPMCH, Dr. Zhuang Liu Qi; China, Nanjing, Dr. Qian Shao-Zhen; China, Chengdu, Dr. Luo She Yuan; China, Beijing, Peking Union Medical College, Dr. Wu Yu-Ming; China Beijing NRIFP, Dr. Wu Shang Chun; China, Beijing O&#x00026;G, Dr. Fan Hui Min; Hungary, Szeged, Dr. G Bartfai; Slovenia, Ljubljana, Dr. M Puksic; Mongolia, Ulaanbaatar State Research Centre on MCH, Dr. R Erdenetungalag; The Philippines, Manila, Dr. R Ramos; Thailand, Bangkok, Chulalongkorn University Hospital, Dr. Damrong Reinprayoon; Tunis, Centre d'Etude et de Recherce en RH, Dr. R Hamszaoui. Study coordinator: Dr. P Rowe. Data Management: Dr. P Rowe, Ms. S. Boccard, Dr. A Peregoudov, Ms. Sihem Landoulsi. Data analysis: Dr. A Peregoudov, Dr. G Piaggio, Dr. T Farley, Dr. P Rowe, Dr. O Meirik. Writing group: Dr. O Meirik, Dr. P Rowe, Dr. G Piaggio, Dr. T Farley, Dr. A Peregoudov.</p></fn></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>9</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>9</month><year>2016</year></pub-date><volume>94</volume><issue>3</issue><fpage>288</fpage><lpage/><permissions><copyright-statement>&#x000a9; 2016 Published by Elsevier Inc.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder/><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><related-article related-article-type="corrected-article" id="d31e12" ext-link-type="doi" xlink:href="10.1016/j.contraception.2016.02.024"/></article-meta></front><body><p>We wish to make the following corrections to our article in the June 2016 issue of Contraception <xref rid="bb0005" ref-type="bibr">[1]</xref>.</p><p>Page 498, first sentence of the Abstract should read: To compare rates of unintended pregnancy, method continuation and reasons for removal among women using the 52-mg levonorgestrel (daily release 20 microg) intrauterine device (LNG-IUD) or the copper T 380 A IUD (TCu380A).</p><p>Page 500, left column, first paragraph, first sentence should read: The trial was initially planned for at least 10 years of follow-up of use of the IUDs.</p><p>Page 504, right column, third paragraph, third sentence should read: The rate of discontinuation due to increased bleeding is slightly higher for the LNG-IUD than for the TCu380A in Chinese centres, while in non-Chinese centres, this pattern is reversed.</p></body><back><ref-list id="bi0005"><title>Reference</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Rowe</surname><given-names>P</given-names></name><name><surname>Farley</surname><given-names>T</given-names></name><name><surname>Peregoudov</surname><given-names>A</given-names></name><name><surname>Piaggio</surname><given-names>G</given-names></name><name><surname>Boccard</surname><given-names>S</given-names></name><name><surname>Landoulsi</surname><given-names>S</given-names></name></person-group><article-title>Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A</article-title><source>Contraception</source><volume>93</volume><year>2016</year><fpage>498</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">26916172</pub-id></element-citation></ref></ref-list></back></article>